Vensica Medical receives US FDA IND clearance to begin phase 2 study of ViXe; a needle-free Xeomin delivery system for overactive bladder: New York Thursday, April 30, 2026, 17:00 ...
Imagine losing your bladder control, vision and muscle strength. Your breathing, swallowing and ability to say words and move ...
Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today ...
Don’t wait to start.
Now, a new scan technique may help spot the condition earlier, a pilot study at Oxford University suggests. The technique ...
We speak to a gynaecologist to learn all about urinary incontinence and how it can be treated ...
From early warning signs to lifestyle changes and screening, here’s how to stay on top of your prostate health ...
Merck (MRK) stock climbed 3% after FDA granted priority review for KEYTRUDA bladder cancer treatment combination, with ...
Back pain can keep you from living life to the fullest, which is why prevention matters. If it strikes, you don’t have to ...
The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...
The FDA has doled out two manufacturing-related complete response letters (CRLs), slamming the brakes on prospective ...
Everyday Health on MSN
Tips for managing metastatic bladder cancer treatment side effects
Learn expert-backed tips for lessening the negative effects of metastatic bladder cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results